The Additive Clinical Value of F-18-FDG PET/CT in Defining the Recurrence of Disease in Patients With Differentiated Thyroid Cancer Who Have Isolated Increased Antithyroglobulin Antibody Levels

ÖZKAN E., SOYDAL Ç., ARAZ M., Aras G., İBİŞ E.

CLINICAL NUCLEAR MEDICINE, cilt.37, sa.8, ss.755-758, 2012 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 37 Sayı: 8
  • Basım Tarihi: 2012
  • Doi Numarası: 10.1097/rlu.0b013e31825ae77b
  • Dergi Adı: CLINICAL NUCLEAR MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.755-758
  • Anahtar Kelimeler: differentiated thyroid cancers, antithyroglobulin antibody, F-18-FDG PET/CT, SERUM THYROGLOBULIN MEASUREMENT, FOLLOW-UP, CARCINOMA, AUTOANTIBODIES, PREVALENCE, SCAN
  • Ankara Üniversitesi Adresli: Evet

Özet

Aim: The aim of this study was to investigate the additive clinical value of F-18-FDG PET/CT in defining the recurrence of disease in patients with differentiated thyroid cancer (DTC) who have isolated increased antithyroglobulin antibody (TgAb) levels with undetectable thyroglobulin (Tg) levels and negative I-131 whole-body scintigraphy (wbs).